Emmaus Life Sciences, Inc. (EMMA) stock
EMMAOTCPharmaceutical PreparationsFiscal year ends December 31
$0.05−0.01 (-14.38%)
Close on Oct 19, 2026Market cap $6.03MP/E –Yield –
Emmaus Life Sciences operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Emmaus Life Sciences's operating cash flow for the twelve months ending Jun 30, 2026 was $3.97M. For fiscal 2025 it was -$11.00K. The highest annual figure on record is -$11.00K in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$11.00K | – |
| FY2024 | Dec 31, 2024 | -$2.29M | – |
| FY2023 | Dec 31, 2023 | -$1.50M | – |
| FY2022 | Dec 31, 2022 | -$5.07M | – |
| FY2021 | Dec 31, 2021 | -$1.25M | – |
| FY2020 | Dec 31, 2020 | -$2.45M | – |
| FY2019 | Dec 31, 2019 | -$4.52M | – |
| FY2017 | Sep 30, 2017 | -$4.79M | – |
| FY2016 | Sep 30, 2016 | -$2.98M | – |
| FY2015 | Sep 30, 2015 | -$2.16M | – |
| FY2014 | Sep 30, 2014 | -$3.27M | – |
| FY2013 | Sep 30, 2013 | -$3.04M | – |
| FY2012 | Sep 30, 2012 | -$2.34M | – |
| FY2011 | Sep 30, 2011 | -$3.57M | – |
| FY2010 | Sep 30, 2010 | -$4.91M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | $1.69M | +393.6% |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | -$344.00K | -332.4% |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | $2.21M | – |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | $409.00K | +192.1% |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | $343.00K | -66.9% |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | $148.00K | +155.2% |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | -$2.92M | – |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | $140.00K | – |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | $1.04M | -38.2% |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | $58.00K | – |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | -$1.31M | – |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | -$1.29M | – |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | $1.68M | +93.9% |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | -$954.00K | -158.2% |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | -$1.06M | -539.3% |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | -$4.73M | – |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | $865.00K | -54.7% |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | $1.64M | – |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | $242.00K | – |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | -$4.00M | -321.3% |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | $1.91M | – |
| Q3 FY2020CQ3 2020 | Sep 30, 2020 | -$2.64M | – |
| Q2 FY2020CQ2 2020 | Jun 30, 2020 | -$3.53M | – |
| Q1 FY2020CQ1 2020 | Mar 31, 2020 | $1.81M | – |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | -$3.26M | – |
| Q3 FY2019CQ3 2018 | Jun 30, 2019 | -$81.00K | – |
| Q4 FY2017CQ3 2017 | Sep 30, 2017 | -$2.12M | – |
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | -$1.07M | – |
| Q2 FY2017CQ1 2017 | Mar 31, 2017 | -$835.30K | – |
| Q1 FY2017CQ4 2016 | Dec 31, 2016 | -$765.80K | – |
| Q4 FY2016CQ3 2016 | Sep 30, 2016 | -$948.50K | – |
| Q3 FY2016CQ2 2016 | Jun 30, 2016 | -$690.00K | – |
| Q2 FY2016CQ1 2016 | Mar 31, 2016 | -$732.40K | – |
| Q1 FY2016CQ4 2015 | Dec 31, 2015 | -$607.50K | – |
| Q4 FY2015CQ3 2015 | Sep 30, 2015 | -$443.80K | – |
| Q3 FY2015CQ2 2015 | Jun 30, 2015 | -$368.90K | – |
| Q2 FY2015CQ1 2015 | Mar 31, 2015 | -$550.00K | – |
| Q1 FY2015CQ4 2014 | Dec 31, 2014 | -$793.70K | – |
See a number that looks wrong?